D-1115-2017 Class II Terminated
FDA drug recall D-1115-2017 was initiated by C. O. Truxton on Apr 20, 2017 and is designated Class II. Reason for recall: Labeling: Label Mixup; potentially mislabeled The recall status is terminated (terminated Sep 11, 2018).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 30, 2017
- Initiation Date
- Apr 20, 2017
- Termination Date
- Sep 11, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10
Reason for recall
Labeling: Label Mixup; potentially mislabeled
Distribution pattern
Nationwide
Code information
Lot # C0260416A; Exp. 03/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1115-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026